Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5887 clinical trials
A Community-Based Educational Intervention to Improve Colorectal Cancer Screening

Learning what encourages people and what keeps people from getting colorectal cancer screening may help researchers develop an educational tool for colorectal cancer screening that addresses colorectal cancer knowledge, beliefs, and cultural factors in underserved populations.

carcinoma
cancer
colorectal cancer
cancer screening
educational intervention
  • 0 views
  • 19 Feb, 2024
Advanced Geriatric Evaluation and Quality of Life in Colorectal Cancer Surgery

Colorectal cancer (CRC) disproportionately affects patients aged 70 years and older. Surgery is the main treatment modality for CRC, but is associated with increased risk of postoperative morbidity, disability and loss of health related quality of life (HRQL).Frailty is an age related state of functional decline and considered to be …

cancer surgery
metastatic colorectal cancer
colorectal cancer
  • 0 views
  • 19 Feb, 2024
Colorectal Cancer Awareness Research and Education and Screening - Rural Expansion Access and Capacity for Health

This study is to assess the impact of the CARES-REACH intervention on colorectal cancer screening rates.

colorectal cancer screening
colorectal cancer
cancer screening
screening for colorectal cancer
  • 0 views
  • 19 Feb, 2024
A Clinical Study of Pyrotinib in Patients of Advanced Colorectal Cancer With Her2 Variation

To Observe the Efficacy and Safety of Pyrotinib Maleate in Patients With Advanced HER2 Variation Colorectal Cancer

pyrotinib
liver metastasis
immunohistochemistry
ejection fraction
neutrophil count
  • 0 views
  • 19 Feb, 2024
Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

EXALT-2 is a prospective, randomized, three arm study for treatment decision guided either by either comprehensive genomic profiling, next generation drug screening or physician's choice

cancer
basal cell carcinoma of the skin
melanoma of the skin
  • 0 views
  • 19 Feb, 2024
Evaluation of the Cell Detachment Ratio on pH-responsive Chitosan as a Prognostic Factor in Lung Cancer

The purpose of this project is to evaluate whether the cell detachment ratio on pH-responsive chitosan could be correlated with the overall survival in lung cancer patients. Through controllable cell-material interaction, this project has the intention to develop an alternative tool for both early diagnosis and accurate prognosis in cancer

  • 0 views
  • 19 Feb, 2024
INvestigational Study Into Transplantation of the Uterus

Observational study on cohort of 10 women undergoing uterine transplantation using deceased donors

  • 0 views
  • 19 Feb, 2024
Cancer Therapy Effects on the Heart

Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) is commonly given to treat pediatric cancer, and carries a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death.

doxorubicin
cancer treatment
metastasis
anthracyclines
cancer therapy
  • 0 views
  • 19 Feb, 2024
Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy

The study's aim is to determinate the prevalence of obstructive sleep apnea hypopnea syndrome after treatment by combined chemoradiotherapy in a locally advanced stages treated population of oropharyngeal cancer. Indeed, the level of knowledge about the consequences of oropharyngeal cancer treatment on sleep quality remains poor but the few studies …

chemoradiotherapy
cancer treatment
obstructive sleep apnea syndrome
oropharyngeal carcinoma
oropharyngeal
  • 0 views
  • 19 Feb, 2024
Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.

chemoradiotherapy
melanoma
stage iii non-small cell lung cancer
immunomodulators
small cell lung cancer
  • 0 views
  • 19 Feb, 2024